124 related articles for article (PubMed ID: 17825261)
21. Periostin-like-factor in osteogenesis.
Zhu S; Barbe MF; Liu C; Hadjiargyrou M; Popoff SN; Rani S; Safadi FF; Litvin J
J Cell Physiol; 2009 Mar; 218(3):584-92. PubMed ID: 19006175
[TBL] [Abstract][Full Text] [Related]
22. Potential of l-thyroxine to differentiate osteoblast-like cells via Angiopoietin1.
Park SH; Lee J; Kang MA; Moon YJ; Wang SI; Kim KM; Park BH; Jang KY; Kim JR
Biochem Biophys Res Commun; 2016 Sep; 478(3):1409-15. PubMed ID: 27569283
[TBL] [Abstract][Full Text] [Related]
23. Rapamycin and cyclosporine have different effects on expression of Ang-1 and Ang-2 and Tie2 in rat renal allograft with chronic allograft nephropathy.
Ma X; Lu YP; Yang L; Song J; Luo GH; Shi YJ; Li YP
Transplant Proc; 2008 Oct; 40(8):2804-7. PubMed ID: 18929866
[TBL] [Abstract][Full Text] [Related]
24. Transgenic disruption of glucocorticoid signaling in mature osteoblasts and osteocytes attenuates K/BxN mouse serum-induced arthritis in vivo.
Buttgereit F; Zhou H; Kalak R; Gaber T; Spies CM; Huscher D; Straub RH; Modzelewski J; Dunstan CR; Seibel MJ
Arthritis Rheum; 2009 Jul; 60(7):1998-2007. PubMed ID: 19565501
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of osteoblastic metalloproteinases in mice prevents bone loss induced by oestrogen deficiency.
Schiltz C; Marty C; de Vernejoul MC; Geoffroy V
J Cell Biochem; 2008 Aug; 104(5):1803-17. PubMed ID: 18384129
[TBL] [Abstract][Full Text] [Related]
26. Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by the CXCR4/stromal cell-derived factor-1 pathway.
Otsuru S; Tamai K; Yamazaki T; Yoshikawa H; Kaneda Y
Stem Cells; 2008 Jan; 26(1):223-34. PubMed ID: 17932420
[TBL] [Abstract][Full Text] [Related]
27. Vascular-specific growth factor angiopoietin 1 is involved in the organization of neuronal processes.
Ward NL; Putoczki T; Mearow K; Ivanco TL; Dumont DJ
J Comp Neurol; 2005 Feb; 482(3):244-56. PubMed ID: 15690488
[TBL] [Abstract][Full Text] [Related]
28. Cutaneous manipulation of vascular growth factors leads to alterations in immunocytes, blood vessels and nerves: Evidence for a cutaneous neurovascular unit.
Ward NL; Hatala DA; Wolfram JA; Knutsen DA; Loyd CM
J Dermatol Sci; 2011 Jan; 61(1):14-22. PubMed ID: 21129919
[TBL] [Abstract][Full Text] [Related]
29. Transgenic mice with osteoblast-targeted insulin-like growth factor-I show increased bone remodeling.
Jiang J; Lichtler AC; Gronowicz GA; Adams DJ; Clark SH; Rosen CJ; Kream BE
Bone; 2006 Sep; 39(3):494-504. PubMed ID: 16644298
[TBL] [Abstract][Full Text] [Related]
30. Enhancement of bone formation by genetically-engineered bone marrow stromal cells expressing BMP-2, VEGF and angiopoietin-1.
Hou H; Zhang X; Tang T; Dai K; Ge R
Biotechnol Lett; 2009 Aug; 31(8):1183-9. PubMed ID: 19390786
[TBL] [Abstract][Full Text] [Related]
31. [The regulation of hypoxia inducible factor-1alpha on osteoblast function in postmenopausal osteoporosis].
Liu XD; Deng LF; Wang J; Qi J; Zhou Q; Wang JS; Wei L; Zhu YP; Clemens T
Zhonghua Wai Ke Za Zhi; 2007 Sep; 45(18):1274-8. PubMed ID: 18067744
[TBL] [Abstract][Full Text] [Related]
32. Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis.
Taura K; De Minicis S; Seki E; Hatano E; Iwaisako K; Osterreicher CH; Kodama Y; Miura K; Ikai I; Uemoto S; Brenner DA
Gastroenterology; 2008 Nov; 135(5):1729-38. PubMed ID: 18823985
[TBL] [Abstract][Full Text] [Related]
33. Angiopoietin 1 inhibits ocular neovascularization and breakdown of the blood-retinal barrier.
Nambu H; Nambu R; Oshima Y; Hackett SF; Okoye G; Wiegand S; Yancopoulos G; Zack DJ; Campochiaro PA
Gene Ther; 2004 May; 11(10):865-73. PubMed ID: 15042118
[TBL] [Abstract][Full Text] [Related]
34. Blockade of receptor-activated G(i) signaling in osteoblasts in vivo leads to site-specific increases in cortical and cancellous bone formation.
Millard SM; Louie AM; Wattanachanya L; Wronski TJ; Conklin BR; Nissenson RA
J Bone Miner Res; 2011 Apr; 26(4):822-32. PubMed ID: 20939063
[TBL] [Abstract][Full Text] [Related]
35. Full-length bovine spp24 [spp24 (24-203)] inhibits BMP-2 induced bone formation.
Sintuu C; Murray SS; Behnam K; Simon R; Jawien J; Silva JD; Duarte ME; Brochmann EJ
J Orthop Res; 2008 Jun; 26(6):753-8. PubMed ID: 18253966
[TBL] [Abstract][Full Text] [Related]
36. Activation of Protein Kinase A in Mature Osteoblasts Promotes a Major Bone Anabolic Response.
Tascau L; Gardner T; Anan H; Yongpravat C; Cardozo CP; Bauman WA; Lee FY; Oh DS; Tawfeek HA
Endocrinology; 2016 Jan; 157(1):112-26. PubMed ID: 26488807
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of SOST/sclerostin by PTH: a novel mechanism of hormonal control of bone formation mediated by osteocytes.
Bellido T
J Musculoskelet Neuronal Interact; 2006; 6(4):358-9. PubMed ID: 17185824
[No Abstract] [Full Text] [Related]
38. Prolactin directly enhances bone turnover by raising osteoblast-expressed receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio.
Seriwatanachai D; Thongchote K; Charoenphandhu N; Pandaranandaka J; Tudpor K; Teerapornpuntakit J; Suthiphongchai T; Krishnamra N
Bone; 2008 Mar; 42(3):535-46. PubMed ID: 18166509
[TBL] [Abstract][Full Text] [Related]
39. Absence of mouse pleiotrophin does not affect bone formation in vivo.
Lehmann W; Schinke T; Schilling AF; Catalá-Lehnen P; Gebauer M; Pogoda P; Gerstenfeld LC; Rueger JM; Einhorn TA; Amling M
Bone; 2004 Dec; 35(6):1247-55. PubMed ID: 15589206
[TBL] [Abstract][Full Text] [Related]
40. Local delivery of COMP-angiopoietin 1 accelerates new bone formation in rat calvarial defects.
Lim SS; Kook SH; Bhattarai G; Cho ES; Seo YK; Lee JC
J Biomed Mater Res A; 2015 Sep; 103(9):2942-51. PubMed ID: 25727390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
